Cargando…

Internal tissue references for (18)Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials

INTRODUCTION: (18)Fluorodeoxyglucose (FDG) positron emission tomography (PET) uptake in the artery wall correlates with active inflammation. However, in part due to the low spatial resolution of PET, variation in the apparent arterial wall signal may be influenced by variation in blood FDG activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahlman, Mark A., Vigneault, Davis M., Sandfort, Veit, Maass-Moreno, Roberto, Dave, Jenny, Sadek, Ahmed, Mallek, Marissa B., Selwaness, Mariana A. F., Herscovitch, Peter, Mehta, Nehal N., Bluemke, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683610/
https://www.ncbi.nlm.nih.gov/pubmed/29131857
http://dx.doi.org/10.1371/journal.pone.0187995
_version_ 1783278323192823808
author Ahlman, Mark A.
Vigneault, Davis M.
Sandfort, Veit
Maass-Moreno, Roberto
Dave, Jenny
Sadek, Ahmed
Mallek, Marissa B.
Selwaness, Mariana A. F.
Herscovitch, Peter
Mehta, Nehal N.
Bluemke, David A.
author_facet Ahlman, Mark A.
Vigneault, Davis M.
Sandfort, Veit
Maass-Moreno, Roberto
Dave, Jenny
Sadek, Ahmed
Mallek, Marissa B.
Selwaness, Mariana A. F.
Herscovitch, Peter
Mehta, Nehal N.
Bluemke, David A.
author_sort Ahlman, Mark A.
collection PubMed
description INTRODUCTION: (18)Fluorodeoxyglucose (FDG) positron emission tomography (PET) uptake in the artery wall correlates with active inflammation. However, in part due to the low spatial resolution of PET, variation in the apparent arterial wall signal may be influenced by variation in blood FDG activity that cannot be fully corrected for using typical normalization strategies. The purpose of this study was to evaluate the ability of the current common methods to normalize for blood activity and to investigate alternative methods for more accurate quantification of vascular inflammation. MATERIALS AND METHODS: The relationship between maximum FDG aorta wall activity and mean blood activity was evaluated in 37 prospectively enrolled subjects aged 55 years or more, treated for hyperlipidemia. Target maximum aorta standardized uptake value (SUV) and mean background reference tissue activity (blood, spleen, liver) were recorded. Target-to-background ratios (TBR) and arterial maximum activity minus blood activity were calculated. Multivariable regression was conducted, predicting uptake values based on variation in background reference and target tissue FDG uptake; adjusting for gender, age, lean body mass (LBM), blood glucose, blood pool activity, and glomerular filtration rate (GFR), where appropriate. RESULTS: Blood pool activity was positively associated with maximum artery wall SUV (β = 5.61, P<0.0001) as well as mean liver (β = 6.23, P<0.0001) and spleen SUV (β = 5.20, P<0.0001). Artery wall activity divided by blood activity (TBR(Blood)) or subtraction of blood activity did not remove the statistically significant relationship to blood activity. Blood pool activity was not related to TBR(liver) and TBR(spleen) (β = −0.36, P = NS and β = −0.58, P = NS, respectively) CONCLUSIONS: In otherwise healthy individuals treated for hyperlipidemia, blood FDG activity is associated with artery wall activity. However, variation in blood activity may mask artery wall signal reflective of inflammation, which requires normalization. Blood-based TBR and subtraction do not sufficiently adjust for blood activity. Warranting further investigation, background reference tissues with cellular uptake such as the liver and spleen may better adjust for variation in blood activity to improve assessment of vascular activity.
format Online
Article
Text
id pubmed-5683610
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56836102017-11-30 Internal tissue references for (18)Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials Ahlman, Mark A. Vigneault, Davis M. Sandfort, Veit Maass-Moreno, Roberto Dave, Jenny Sadek, Ahmed Mallek, Marissa B. Selwaness, Mariana A. F. Herscovitch, Peter Mehta, Nehal N. Bluemke, David A. PLoS One Research Article INTRODUCTION: (18)Fluorodeoxyglucose (FDG) positron emission tomography (PET) uptake in the artery wall correlates with active inflammation. However, in part due to the low spatial resolution of PET, variation in the apparent arterial wall signal may be influenced by variation in blood FDG activity that cannot be fully corrected for using typical normalization strategies. The purpose of this study was to evaluate the ability of the current common methods to normalize for blood activity and to investigate alternative methods for more accurate quantification of vascular inflammation. MATERIALS AND METHODS: The relationship between maximum FDG aorta wall activity and mean blood activity was evaluated in 37 prospectively enrolled subjects aged 55 years or more, treated for hyperlipidemia. Target maximum aorta standardized uptake value (SUV) and mean background reference tissue activity (blood, spleen, liver) were recorded. Target-to-background ratios (TBR) and arterial maximum activity minus blood activity were calculated. Multivariable regression was conducted, predicting uptake values based on variation in background reference and target tissue FDG uptake; adjusting for gender, age, lean body mass (LBM), blood glucose, blood pool activity, and glomerular filtration rate (GFR), where appropriate. RESULTS: Blood pool activity was positively associated with maximum artery wall SUV (β = 5.61, P<0.0001) as well as mean liver (β = 6.23, P<0.0001) and spleen SUV (β = 5.20, P<0.0001). Artery wall activity divided by blood activity (TBR(Blood)) or subtraction of blood activity did not remove the statistically significant relationship to blood activity. Blood pool activity was not related to TBR(liver) and TBR(spleen) (β = −0.36, P = NS and β = −0.58, P = NS, respectively) CONCLUSIONS: In otherwise healthy individuals treated for hyperlipidemia, blood FDG activity is associated with artery wall activity. However, variation in blood activity may mask artery wall signal reflective of inflammation, which requires normalization. Blood-based TBR and subtraction do not sufficiently adjust for blood activity. Warranting further investigation, background reference tissues with cellular uptake such as the liver and spleen may better adjust for variation in blood activity to improve assessment of vascular activity. Public Library of Science 2017-11-13 /pmc/articles/PMC5683610/ /pubmed/29131857 http://dx.doi.org/10.1371/journal.pone.0187995 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Ahlman, Mark A.
Vigneault, Davis M.
Sandfort, Veit
Maass-Moreno, Roberto
Dave, Jenny
Sadek, Ahmed
Mallek, Marissa B.
Selwaness, Mariana A. F.
Herscovitch, Peter
Mehta, Nehal N.
Bluemke, David A.
Internal tissue references for (18)Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials
title Internal tissue references for (18)Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials
title_full Internal tissue references for (18)Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials
title_fullStr Internal tissue references for (18)Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials
title_full_unstemmed Internal tissue references for (18)Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials
title_short Internal tissue references for (18)Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials
title_sort internal tissue references for (18)fluorodeoxyglucose vascular inflammation imaging: implications for cardiovascular risk stratification and clinical trials
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683610/
https://www.ncbi.nlm.nih.gov/pubmed/29131857
http://dx.doi.org/10.1371/journal.pone.0187995
work_keys_str_mv AT ahlmanmarka internaltissuereferencesfor18fluorodeoxyglucosevascularinflammationimagingimplicationsforcardiovascularriskstratificationandclinicaltrials
AT vigneaultdavism internaltissuereferencesfor18fluorodeoxyglucosevascularinflammationimagingimplicationsforcardiovascularriskstratificationandclinicaltrials
AT sandfortveit internaltissuereferencesfor18fluorodeoxyglucosevascularinflammationimagingimplicationsforcardiovascularriskstratificationandclinicaltrials
AT maassmorenoroberto internaltissuereferencesfor18fluorodeoxyglucosevascularinflammationimagingimplicationsforcardiovascularriskstratificationandclinicaltrials
AT davejenny internaltissuereferencesfor18fluorodeoxyglucosevascularinflammationimagingimplicationsforcardiovascularriskstratificationandclinicaltrials
AT sadekahmed internaltissuereferencesfor18fluorodeoxyglucosevascularinflammationimagingimplicationsforcardiovascularriskstratificationandclinicaltrials
AT mallekmarissab internaltissuereferencesfor18fluorodeoxyglucosevascularinflammationimagingimplicationsforcardiovascularriskstratificationandclinicaltrials
AT selwanessmarianaaf internaltissuereferencesfor18fluorodeoxyglucosevascularinflammationimagingimplicationsforcardiovascularriskstratificationandclinicaltrials
AT herscovitchpeter internaltissuereferencesfor18fluorodeoxyglucosevascularinflammationimagingimplicationsforcardiovascularriskstratificationandclinicaltrials
AT mehtanehaln internaltissuereferencesfor18fluorodeoxyglucosevascularinflammationimagingimplicationsforcardiovascularriskstratificationandclinicaltrials
AT bluemkedavida internaltissuereferencesfor18fluorodeoxyglucosevascularinflammationimagingimplicationsforcardiovascularriskstratificationandclinicaltrials